科泰電源(300153.SZ):擬申請認定外資研發中心
格隆匯11月12日丨科泰電源(300153.SZ)公佈,公司第五屆董事會第七次會議決議,審議通過《關於公司申請認定外資研發中心的議案》 。
公司重視技術研發工作,組建了研發中心,配備了相關設備和專業人員。近年來,公司進一步加強了技術研發相關工作。根據《上海市鼓勵設立和發展外資研發中心的規定》,上海市商務委及相關部門將給予符合條件的外資研發中心相關政策扶持促進和便利措施。公司擬充分利用上海資源優勢,申請認定外資研發中心。外資研發中心的認定,有利於為公司持續發展提供有力保證,同時可以進一步提升公司形象,更好地吸引高端技術人才加入公司團隊,進一步增強公司研發實力、科技創新能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.